Certified by Founder Lodge
Viking Global Investors
United States - Greenwich, Connecticut
INVESTOR
1 Disclosed Funding Rounds $401,000,000
27 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Viking Global Investors LP (“Viking”) is a global investment firm founded in 1999. We employ a fundamentals-driven investment approach to managing over $40 billion of capital across long/sho
| Company | Date | Round | Raised |
|---|---|---|---|
ID.me |
April, 12 ,2023 | Series D | $132,000,000 |
Arctic Wolf |
October, 06 ,2022 | Unknown | $401,000,000 |
Abdera Therapeutics |
April, 24 ,2023 | Series B | $142,000,000 |
Ensoma |
February, 06 ,2023 | Series B | $85,000,000 |
Solarea Bio |
May, 09 ,2023 | Series B | $15,000,000 |
AlphaSense |
June, 15 ,2022 | Series D | $225,000,000 |
Pragma Bio |
March, 27 ,2023 | Unknown | $10,000,000 |
Lightmatter |
June, 01 ,2023 | Series C | $154,000,000 |
Global Processing Services |
January, 13 ,2022 | Unknown | $100,000,000 |
DermBiont, Inc. |
October, 25 ,2023 | Series B | $35,200,000 |
ID.me |
April, 12 ,2023 | Series D | $132,000,000 |
Triveni Bio |
October, 27 ,2023 | Series A | $92,000,000 |
Abdera Therapeutics |
April, 24 ,2023 | Series B | $142,000,000 |
HI-Bio |
January, 05 ,2024 | Series B | $95,000,000 |
Solarea Bio |
May, 09 ,2023 | Series B | $15,000,000 |
Valsoft Corporation |
January, 22 ,2024 | Unknown | $170,000,000 |
Lightmatter |
June, 01 ,2023 | Series C | $154,000,000 |
Sionna Therapeutics |
March, 07 ,2024 | Series C | $182,000,000 |
DermBiont, Inc. |
October, 25 ,2023 | Series B | $35,200,000 |
Antheia, Inc. |
July, 23 ,2024 | Unknown | $17,000,000 |
Triveni Bio |
October, 27 ,2023 | Series A | $92,000,000 |
Metsera |
November, 14 ,2024 | Series B | $215,000,000 |
HI-Bio |
January, 05 ,2024 | Series B | $95,000,000 |
Valsoft Corporation |
January, 22 ,2024 | Unknown | $170,000,000 |
Sionna Therapeutics |
March, 07 ,2024 | Series C | $182,000,000 |
Antheia, Inc. |
July, 23 ,2024 | Unknown | $17,000,000 |
Metsera |
November, 14 ,2024 | Series B | $215,000,000 |
ID.me
Arctic Wolf
Abdera Therapeutics
Ensoma
Solarea Bio
AlphaSense
Pragma Bio
Lightmatter
Global Processing Services
DermBiont, Inc.
Triveni Bio
HI-Bio
Valsoft Corporation
Sionna Therapeutics
Antheia, Inc.
Metsera
dezerv.
FalconX
Kristal.AI
Finary
Savart
Sizable Energy | $8,000,000 | (Oct 24, 2025)
Sumble | $38,500,000 | (Oct 24, 2025)
Syntracts | $5,300,000 | (Oct 24, 2025)
Cybrid | $10,000,000 | (Oct 24, 2025)
Elevara Medicines | $70,000,000 | (Oct 24, 2025)